Env-Specific CTL Predominate in Cats Protected from Feline Immunodeficiency Virus Infection by Vaccination

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3658-3665

  Flynn, J Norman ^a   Keating, Paula ^a   Hosie, Margaret J ^a   Mackett, Mike ^b   Stephens, Edward B ^c   Beatty, Julia A ^a   Neil, James C ^a   Jarrett, Oswald ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; CAT; CAT DISEASE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPH NODE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; CATS; CD8-POSITIVE T-LYMPHOCYTES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HIV-1; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOLOGIC MEMORY; LYMPH NODES; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 0030587870     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Barlough, J. E., C. D. Ackley, J. W. George, N. Levy, R. Acevedo, P. F. Moore, B. A. Rideout, M. D. Cooper, and N. C. Pedersen. 1991. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency infection: comparison of short-term and long-term infections. J. Acquired Immune Defic. Syndr. 4:219.
2. + cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol. 66:1484.
3. Ishida, T., T. Washizu, K. Toriyabe, S. Motoyoshi, I. Tomoda, and N. C. Pedersen. 1989. Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc. 194:221.
4. Diehl, L. J., C. K. Mathiason-DuBard, L. L. O'Neil, and E. A. Hoover. 1995. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a competitive reverse transcriptase PCR. J. Virol. 69:2328.
5. Bach, J.-M., M. Hurtrel, L. Chakrabarti, J.-P. Ganiere, L. Montagnier, and B. Hurtrel. 1994. Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. AIDS Res. Hum. Retroviruses 10:1731.
6. Beebe, A. M., N. Dua, T. G. Faith, P. F. Moore, N. C. Pedersen, and S. Dandekar. 1994. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68:3080.
7. Toyosaki, T., T. Miyazawa, T. Furuya, K. Tomonga, Y.-S. Shin, M. Okita, Y. Kawaguchi, C. Kai, S. Mori, and T. Mikami. 1993. Localization of viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection. Arch. Virol. 131:335.
8. Ishida, T., and I. Tomoda. 1990. Clinical staging of feline immunodeficiency virus infection. Nippon Juigaku Zasshi 52:645.
9. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790.
10. Nixon, D. F. 1992. The cytotoxic T cell response to HIV. In Immunology of HIV. G. Bird, ed. Kluwer Academic Publishers, Liverpool, U.K., pp. 59-89.
11. Baltimore, D., and M. B. Feinberg. 1989. HIV revealed: toward a natural history of the infection. N. Engl. J. Med. 321:1673.
12. Sethi, K., H. Naher, and I. Stroehmann. 1988. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature 335:178.
13. Plata, F., B. Autran, L. Pedroza-Martins, S. Wain-Hobson, M. Raphael, C. Mayaud, M. Denis, J. M. Guillon, and P. Debre. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328:348.
14. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452.
15. Nixon, D. F., K. Broliden, G. Ogg, and P.-A. Proliden. 1992. Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 76:515.
16. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, B. Guy, M.-P. Kieny, F. Drefus, A.-G., Saimot, D. Sereni, D. Sicard, J.-P. Levy, and E. Gomard. 1992. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 6:1249.
17. Chenyier, R., P. Langlade-Demoyen, M.-R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211.
18. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposcd but uninfected infant. Lancet 241:860.
19. Bryson, Y. J., S. Pang, L. S. Wei, R. Dickover, A. Diagne, and I. S. Y. Chen. 1995. Clearance of HIV infection in a perinatally infected infant. N. Engl. J. Med. 332:833-838.
20. Rowland-Jones, S. L., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schulz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59.
21. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency type 1 syndrome. J. Virol. 68:4650.
22. Mackewicz, C. E., L. C. Yang, J. D. Lifson, and J. A. Levy. 1994. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344:1671.
23. Song, W., E. W. Collisson, P. M. Billingsley, and W. C. Brown. 1992. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66:5409.
24. Beatty, J. A. 1994. Studies on the cellular immune response to feline immunodeficiency virus. Doctoral dissertation. University of Glasgow, Glasgow, Scotland.
25. Hosie, M. J. 1994. The development of a vaccine against feline immunodeficiency virus. Br. Vet. J. 150:25.
26. Hosie, M. J., R. Osborne, J. K. Yamamoto, J. C. Neil, and O. Jarrett. 1995. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J. Virol. 69:1253.
27. Flynn, J. N., J. A. Beatty, C. A. Cannon, E. B. Stephens, M. J. Hosie, J. C. Neil, and O. Jarrett. 1995. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res. Hum. Retroviruses 11:1107.
28. Yamamoto, J. K., C. D. Ackley, H. Zochlinski, H. Louie, E. Pembroke, M. Torten, H. Hansen, R. Munn, and T. Okuda. 1991. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines. Intervirology 32:361.
29. + lymphocyte subset. Immunology 78:1.
30. Flynn, J. N., C. A. Cannon, J. A. Beatty, M. Mackett, M. A. Rigby, J. C. Neil, and O. Jarrett. 1994. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J. Virol. 68:5835.
31. Stephens, E. B., E. J. Butfiloski, and E. Monck. 1992. Analysis of the amino terminal presequenee of the feline immunodeficiency virus glycoprotein: effect of deletions on the intracellular transport of gp95. Virology 190:569.
32. + T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 7:781.
33. Lubaki, M. N., M. A. Egan, R. F. Siliciano, K. J. Weinhold, and R. C. Bollinger. 1994. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 11:1427.
34. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox. J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of the disease. Nature 362:355.
35. Embretson, J., M. Zupanic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Hasse. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
36. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345.
37. Holt, C. A., K. Osoio, and J. C. Kaplan. 1986. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene encoded specificities. J. Exp. Med. 164:211.
38. Plata, F., P. Langlade-Demoyen, J. P. Abastado, T. Berbaz, and P. Kourlisky. 1987. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell 48:231.
39. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, B. Guy, T. D. Ly, C. Goujard, J.-G. Guillet, and E. Gomard. 1995. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9:421.
40. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. 1994. Virus-specific cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.
41. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463.
42. Johnson, R. P., and B. D. Walker. 1994. Cytotoxic T lymphocytes in HIV infection: responses to structural proteins. Curr. Top. Microbiol. Immunol. 189:35.
43. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type I (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-I-infected long-term nonprogressors. J. Virol. 69:5838.
44. Weinhold, K. J., H. K. Lyerly, T. J. Matthews, D. S. Tyler, P. M. Ahearne, K. C. Stine, A. J. Langlois, D. T. Durack, and D. P. Bolognesi. 1988. Cellular anti-gp120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet 1:902.
45. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M.-P., Kieny, J.-J. Fournel, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing Gag and Env proteins. J. Virol. 63:2270.
46. + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J. Virol. 66:608.
47. + human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res. Hum. Retroviruses 9:61.